
The Duke Division of Pulmonary, Allergy, and Critical Care Medicine offers patients access to new therapies through participation in carefully designed clinical trials.Ĭurrent clinical research trials are being conducted in relation to the following topics. Learn more about the Duke Lung Transplant Research Program. Medical Director, Duke Children's Hospital Pulmonary Function Laboratory. P142 The distribution of blood eosinophil count in a copd clinical trials database: comparing the. Medical Director, Duke Children's Hospital Sleep Program. were any GlaxoSmithKline Research and Development or.
#Free clinical trials and research for copd at duke trial#
The endpoints of the trial are the primary outcome measure (ie, CE-COPD) and the primary outcome predictor (ie. Summary Descriptive Statistics of Initial and. Moreover, innovative translational studies have demonstrated certain genetic immune variants are protective against post-transplant rejection and have provided new insights into the mechanisms that lead to organ rejection. The American Lung Association Airways Clinical Research Centers (ACRC) Network attracts some of the best asthma and COPD investigators nationwide. All Days Analysis (Only CE-COPD-free Days). This discovery has already led to innovative therapies to prevent and treat GER and improve patient outcomes. Researchers in our lung transplant program linked gastroesophageal reflux (GER) to long-term pulmonary complications after transplantation. Our program is actively engaged in clinical research activities to advance our knowledge about the diagnosis and treatment of airway invasion by lung cancer and malignant pleural effusions. The Interstitial Lung Disease Clinic at Duke is participating in several multi-center clinical trials to test new and promising medications for treatment of idiopathic pulmonary fibrosis. Learn more about how hyperbaric medicine is used to treat pulmonary alveolar proteinosis.

Patients with this rare lung disease are asked to register with the center for participation in ongoing clinical research. Pulmonary researchers in this center are examining causes and treatments of pulmonary alveolar proteinosis. A Snapshot of Current Clinical Research in Our Division Duke Center for Hyperbaric Medicine and Environmental Physiology

The Duke Division of Pulmonary, Allergy, and Critical Care Medicine is actively involved in clinical research that advances the understanding and treatment of patients with pulmonary dysfunction and the critically ill.
